KIMBERLY BASHAM: Open Payments
NPI 1790154169 · THE VILLAGES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$727 in 6 payments from 5 companies in 2025. Trend: 2023 $123 · 2024 $455 · 2025 $727
Food & beverage: $727
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $245 |
| Dexcom, Inc. | 1 | $131 |
| Amgen Inc. | 1 | $124 |
| GlaxoSmithKline, LLC. | 1 | $123 |
| Averitas Pharma Inc. | 1 | $105 |
Products named: DEXCOM G7 GSS (161), REPATHA, BENLYSTA, ZEPBOUND, QUTENZA.
Industry payments across FL — which companies pay providers there.
